Using these optimised IHC conditions, we proceeded to investigate CDK18 protein expression in the Nottingham Tenovus series of 1650 breast cancers for which detailed clinicopathological parameters and various molecular markers have been previously defined [18–21]. This evidence concerns the gene CDK18 and breast carcinoma.